Orthofix Medical Inc.

NASDAQ:OFIX

Medical - Devices

Healthcare
$6.61 +0.33%

+$0.03 today

Market cap
$269.42M
Beta
0.71
P/E (TTM)
-6.2
EPS (TTM)
-$1.48
52W Low $9.12High $16.99

Volume 0.40M

Average 0.38M

OFIX Other Investing Activities

Investing cash flows not reported separately.

Orthofix Medical Inc.NASDAQ: OFIX

Other Investing Activities · Q1 FY2026 · quarter ended Mar 2026

Other investing activities outflow grows to $146K

Q1 FY2026 other investing activities was $146K, compared with $0 a year earlier. Trailing-twelve-month other investing activities was $9.88M. Over 3 fiscal years it compounded at +193.1% a year.

Context

  • Other investing activities amounted to 4.2% of revenue in FY2025, up 4.2 pp from a year earlier.
  • Other investing activities grew in size in 1 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly other investing activities holds near $146K or moves back toward the trailing-twelve-month quarterly average of $2.47M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$146K-98.5% QoQ
Last fiscal yearDec 2025
-$34.6M+34498.0% YoY
LTMMar 2026
$9.88M+34.5% YoY
Other Investing Activities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year+34498.0%——
3-year CAGR+193.1%——
5-year CAGR——
10-year CAGR——

Other Investing Activities history

USD · from the cash flow

Latest · FY2025
(34.6M) USD
Year-over-year change
-34498.0%

Other Investing Activities vs competitors

How OFIX compares with its peers on the latest reported figures

  • OFIX's LTM Mar 2026 other investing activities of $9.88M is the 3rd largest of the 11 companies compared; the peer median is $0.
  • Its year-over-year change of +34.5% is the 2nd highest of 7, against a peer median of -51.8%.
  • Other investing activities amounts to 1.2% of revenue for OFIX, versus a peer median of 0.0%.
OFIX Competitors Peer median
Other Investing Activities for OFIX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
AVNSAvanos Medical, Inc.LTM Mar 2026$24.7M +109.3%—3.5%
LABStandard BioTools Inc.LTM Mar 2026$18.6M -39.0%-61.0%21.6%
OFIXOrthofix Medical Inc.LTM Mar 2026$9.88M +34.5%+193.1%1.2%
PACBPacific Biosciences of California, Inc.LTM Mar 2026$1.9M -62.0%+203.4%1.2%
VREXVarex Imaging CorporationLTM Apr 2026$700K -41.7%-25.0%0.1%
BFLYButterfly Network, Inc.LTM Mar 2026$0 -100.0%—0.0%
ABSIAbsci CorporationLTM Mar 2026$0 -100.0%—0.0%
MLTXMoonLake ImmunotherapeuticsLTM Mar 2026$0 ———
SIBNSI-BONE, Inc.LTM Mar 2026$0 ——0.0%
ESPREsperion Therapeutics, Inc.LTM Mar 2026$0 ——0.0%
DRIODarioHealth Corp.LTM Mar 2026$0 ——0.0%
Peer median (excluding OFIX) $0-51.8%-25.0%0.0%

Competitors are the stored peer set for OFIX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(38.38M)(19.75M)(151.4M)(126M)(92.19M)
Depreciation & Amortization33.1M32.08M60.6M75.96M83.26M
Deferred Income Tax24.48M314K579K1.88M223K
Stock-Based Compensation15.43M18.44M35.71M32.46M28.69M
Change in Working Capital(18.1M)(29.24M)(53.96M)(19.25M)(21.5M)
Accounts Receivables(7.05M)(6.74M)(10.41M)(9.53M)(1.58M)
Inventory619K(18.13M)(58.05M)(5.55M)(10.75M)
Accounts Payables4.25M2.28M8.64M(5.57M)2.6M
Other Working Capital(15.93M)(6.65M)5.86M1.39M(11.77M)
Other Non-Cash Items1.95M(13.39M)62.72M60.74M54.84M
Operating Cash Flow18.48M(11.54M)(45.75M)25.79M33.35M
Capital Expenditures(19.59M)(23.16M)(62.05M)(34.88M)(34.63M)
Acquisitions (Net)0(1.5M)29.42M00
Purchases of Investments(2.17M)0000
Sales of Investments0126K07.4M0
Other Investing Activities(1.25M)(1.37M)(500K)(100K)(34.6M)
Investing Cash Flow(23.01M)(24.53M)(33.13M)(27.58M)(34.6M)
Debt Repayment(537K)(2.59M)67.95M54.39M(762K)
Common Stock Issued8.82M4.34M5.13M6.26M5.93M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(11.91M)(1.82M)(7.75M)(9.94M)(5.95M)
Financing Cash Flow(3.62M)(78K)65.32M50.71M(786K)
Effect of Forex Changes(815K)(997K)619K(938K)1.41M
Net Change in Cash(8.97M)(37.15M)(12.94M)47.98M(623K)
Free Cash Flow(1.12M)(34.7M)(107.8M)(9.09M)(1.28M)

Orthofix Medical Inc.

NASDAQ:OFIX

Intrinsic Alpha fair value

Locked

Current Price

$6.61

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.